About Single Cell Technology
Single Cell Technology is a company based in San Jose (United States) founded in 2008. Single Cell Technology has raised $2.46 million across 3 funding rounds. The company has 9 employees as of December 31, 2022. Single Cell Technology offers products and services including AbTheneum Platform. Single Cell Technology operates in a competitive market with competitors including Omniome, Adimab, Novogene Corporation, HitGen and Singular Genomics, among others.
- Headquarter San Jose, United States
- Employees 9 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.46 M (USD)
in 3 rounds
-
Latest Funding Round
$2.14 M (USD), Seed
Jan 22, 2021
-
Investors
Not available
-
Employee Count
9
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Single Cell Technology
Single Cell Technology offers a comprehensive portfolio of products and services, including AbTheneum Platform.
Platform that captures data for efficient antibody discovery processes.
People of Single Cell Technology
Unlock access to complete
Unlock access to complete
Funding Insights of Single Cell Technology
Single Cell Technology has successfully raised a total of $2.46M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2.14 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Single Cell Technology
Investment portfolio details for Single Cell Technology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Single Cell Technology
Detailed financials for Single Cell Technology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Single Cell Technology Comparisons
Peer comparison for Single Cell Technology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Single Cell Technology
Single Cell Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Adimab, Novogene Corporation, HitGen and Singular Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
Antibodies are discovered and optimized for autoimmune and infectious diseases.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Next-generation gene sequencing and multi-omics technologies are provided.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and infectious diseases are developed.
|
Detailed competitors of Single Cell Technology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Single Cell Technology
Complete news archive for Single Cell Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Single Cell Technology
Single Cell Technology was founded in 2008 and raised its 1st funding round 4 years after it was founded.
Single Cell Technology is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Single Cell Technology is a funded company, having raised a total of $2.46M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Single Cell Technology is 9.
Single Cell Technology develops and licenses a technology platform that discovers and analyzes antibodies and mRNA from individual antibody-secreting cells. Its platform examines and screens plasma cells in lymphoid tissues against various molecules in various hosts, including humans, mouse cells, and other organisms for measuring their affinity and specificity from cognate light and heavy chains. It also provide the DNA sequences of the antibody cognate light and heavy chains, and structural inference for each antibody. It is involved in contract services for the antibody repertoire of the immune response to pharmaceutical and biopharmaceutical companies.
Single Cell Technology's top competitors include Adimab, Novogene Corporation and BGI.
Single Cell Technology offers AbTheneum Platform.